Pacira BioSciences Announces Exclusive Agreement With Molteni Farmaceutici To Commercialize EXPAREL In Europe; Pacira To Receive Undisclosed Upfront Payment Plus Royalties
Share
Why It Matters
Pacira made a deal to sell a pain medicine in Europe. They will get money now and more money later from sales.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.